Clinical Impact of Single and Dual Antiplatelet Therapy Beyond 12 Months on Ischemic Risk in Patients With Acute Myocardial Infarction

Clinical Impact of Single and Dual Antiplatelet Therapy Beyond 12 Months on Ischemic Risk in Patients With Acute Myocardial Infarction

Background: There is ongoing debate regarding the optimal antiplatelet strategy beyond 12 months in patients with acute myocardial infarction (AMI) who undergo successful percutaneous coronary intervention (PCI). This study therefore aimed to investigate the clinical outcomes of single (SAPT) vs. du...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Ji Woong Roh, SungA Bae, Yongcheol Kim, Nak-Hoon Son, Deok-Kyu Cho, Jung-Sun Kim, Byeong-Keuk Kim, Donghoon Choi, Myeong-Ki Hong, Myung Ho Jeong, Yangsoo Jang, the KAMIR-NIH Investigators
Format: article
Langue:EN
Publié: Frontiers Media S.A. 2021
Sujets:
acute myocardial infarction
antiplatelet therapy
aspirin
clopidogrel
major adverse cardiac and cerebral event
Diseases of the circulatory (Cardiovascular) system
RC666-701
Accès en ligne:https://doaj.org/article/9b981fb1b590491c8d5af377adadd2e1
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/9b981fb1b590491c8d5af377adadd2e1

Documents similaires